PRKN and renal fibrosis: For instance, Mdivi-1, a mitochondrial inhibitor, can reduce the expression levels of PINK1, PARK2, and LC3II, activate the TGF-β1 signaling pathway in HK-2 cells under hypoxic conditions, thereby exacerbating renal fibrosis [30].